Prediabetes and Lifestyle Modification: Time to Prevent a Preventable Disease
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
More than 100 million Americans have prediabetes or diabetes. Prediabetes is a condition in which individuals have blood glucose levels higher than normal but not high enough to be classified as diabetes. People with prediabetes have an increased risk of Type 2 diabetes. An estimated 34% of adults have prediabetes. Prediabetes is now recognized as a reversible condition that increases an individual's risk for development of diabetes. Lifestyle risk factors for prediabetes include overweight and physical inactivity.Increasing awareness and risk stratification of individuals with prediabetes may help physicians understand potential interventions that may help decrease the percentage of patients in their panels in whom diabetes develops. If untreated, 37% of the individuals with prediabetes may have diabetes in 4 years. Lifestyle intervention may decrease the percentage of prediabetic patients in whom diabetes develops to 20%.Long-term data also suggest that lifestyle intervention may decrease the risk of prediabetes progressing to diabetes for as long as 10 years. To prevent 1 case of diabetes during a 3-year period, 6.9 persons would have to participate in the lifestyle intervention program. In addition, recent data suggest that the difference in direct and indirect costs to care for a patient with prediabetes vs a patient with diabetes may be as much as $7000 per year. Investment in a diabetes prevention program now may have a substantial return on investment in the future and help prevent a preventable disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies have demonstrated that weight loss and exercise can usually delay progression to T2D, or even prevent T2D from manifesting; lifestyle interventions reduce the risk of T2D progression in 40–70% of adults with prediabetes.91,92”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [92]
In the citing paper
“Reducing demand on the islet beta-cells by improving insulin sensitivity through weight loss and/or pharmacological means has been reported to improve T2D prognosis and delay/prevent pre-diabetic individuals progressing to T2D, suggesting that inducing “beta-cell rest” to even a degree alleviates the pathology that is associated with this disease.92,98”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [92]
In the citing paper
“Reducing demand on the islet beta-cells by improving insulin sensitivity through weight loss and/or pharmacological means has been reported to improve T2D prognosis and delay/prevent pre-diabetic individuals progressing to T2D, suggesting that inducing “beta-cell rest” to even a degree alleviates the pathology that is associated with this disease.92,98”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [92]
Citations
Cites
Home visits: a strategy to improve newborn survival - Authors' reply
(2008) · Americanae (AECID Library) · doi:10.1016/s0140 · Cited by 22,524
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
Cited by
Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management
Chaudhury, A., Duvoor, C., Reddy Dendi, V. S., Kraleti, S., Chada, A., Ravilla, R., Marco, A., Shekhawat, N. S., Montales, M. T., Kuriakose, K., et al. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00006 · Cited by 1,500
Role of Skeletal Muscle in Insulin Resistance and Glucose Uptake
Merz, K. E., & Thurmond, D. C. (2020) · Comprehensive Physiology · doi:10.1002/cphy.c190029 · Cited by 494
From pre-diabetes to diabetes: diagnosis, treatments and translational research
Khan, R., Chua, Z., Tan, J., Yang, Y., Liao, Z., & Zhao, Y. (2019) · Medicina · doi:10.3390/medicina55090546 · Cited by 484
“Pre-diabetes is seen as the critical phase, because studies have shown that at this stage, the condition is reversible and could serve as a potential route to combat diabetes [41,45].”
BackgroundReed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441
Bodai, B. I., & Tuso, P. (2015) · The Permanente Journal · doi:10.7812/tpp/14-241 · Cited by 397
Self-citationKocher, T., König, J., Borgnakke, W. S., Pink, C., & Meisel, P. (2018) · Periodontology 2000 · doi:10.1111/prd.12235 · Cited by 293
Dynamics of diabetes and obesity: Epidemiological perspective
Boles, A., Kandimalla, R., & Reddy, P. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.01.016 · Cited by 263
“Also, additional complications that are particularly relevant to pre-diabetes include: (1) nephropathies and chronic kidney disease, (2) neuropathies, (3) diabetic retinopathy, and (4) macrovascular diseases [111-113].”
Predicting Type 2 Diabetes Using Logistic Regression and Machine Learning Approaches
Joshi, R. D., & Dhakal, C. K. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18147346 · Cited by 260
Papakonstantinou, E., Oikonomou, C., Nychas, G., & Dimitriadis, G. D. (2022) · Nutrients · doi:10.3390/nu14040823 · Cited by 199
Ahmad, H. F., Mukhtar, H., Alaqail, H., Seliaman, M. E., & Alhumam, A. (2021) · Applied Sciences · doi:10.3390/app11031173 · Cited by 108
“From a medical point of view, it is possible to avoid DM at an early stage or at least control its complications [21].”
BackgroundStem-cell based organ-on-a-chip models for diabetes research
Rogal, J., Zbinden, A., Schenke‐Layland, K., & Loskill, P. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.010 · Cited by 93
Goedeke, L., Perry, R. J., & Shulman, G. I. (2019) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104727 · Cited by 77
“As such, current therapy for T2D relies mainly on the following approaches intended to reduce hyperglycemia(12): lifestyle modifications, which include the adoption of a healthy diet, increased physical activity, and healthy body weight maintenance (13); metformin, which acts to reduce hepatic gluconeogenesis and hepa…”
BackgroundReview of Metformin Use for Type 2 Diabetes Prevention
Moin, T., Schmittdiel, J. A., Flory, J. H., Yeh, J., Karter, A. J., Kruge, L. E., Schillinger, D., Mangione, C. M., Herman, W. H., & Walker, E. A. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.04.038 · Cited by 75
Rajpal, A., & Ismail‐Beigi, F. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14080 · Cited by 70
Al-Muhtaresh, H. A., & Al‐Kafaji, G. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7020012 · Cited by 73
“Considering that lifestyle modifications could delay and even prevent the progression to T2D in high-risk subjects [15,16], biomarkers for early detection of prediabetes and T2D are therefore important in future preventive interventions, which would greatly improve the care of these patients.”
BackgroundInfluentialIn Vitro and In Vivo Antidiabetic Potential of Monoterpenoids: An Update
Kury, L. T. A., Abdoh, A., Ikbariah, K., Sadek, B. S., & Mahgoub, M. (2021) · Molecules · doi:10.3390/molecules27010182 · Cited by 78
Wan, C. C., Ouyang, J., Li, M., Rengasamy, K. R. R., & Liu, Z. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2157372 · Cited by 69
“…an essential component in the management of diabetes—both in its prevention and in treatment—because it not only helps in achieving the glycemic goal but also reduces cardiovascular risk by positively affecting blood pressure and cholesterol levels (Tuso 2014; Strelitz et al. 2022; Wilding 2014).”
BackgroundSiti Halimatul Munawaroh, H., Gumilar, G. G., Nurjanah, F., Yuliani, G., Aisyah, S., Kurnia, D., Wulandari, A. P., Kurniawan, I., Ningrum, A., Koyande, A. K., et al. (2020) · Biochemical Engineering Journal · doi:10.1016/j.bej.2020.107666 · Cited by 61
Vitamin D deficiency in the aetiology of obesity‐related insulin resistance
Pramono, A., Jocken, J. W. E., & Blaak, E. E. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3146 · Cited by 73
Barrett, S., Begg, S. J., O’Halloran, P., & Kingsley, M. (2018) · BMC Public Health · doi:10.1186/s12889-018-6064-7 · Cited by 65
Shamizadeh, T., Jahangiry, L., Sarbakhsh, P., & Ponnet, K. S. (2019) · Trials · doi:10.1186/s13063-019-3220-z · Cited by 68
An Update on the Molecular and Cellular Basis of Pharmacotherapy in Type 2 Diabetes Mellitus
Mahgoub, M., Ali, I. I., Adeghate, J. O., Tekes, K., Kalász, H., & Adeghate, E. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119328 · Cited by 74
“A study conducted on individuals with pre-diabetes showed a 20% reduction in the incidence of DM after adopting a healthy lifestyle compared to those with an unhealthy diet and sedentary lifestyle [66,67].”
BackgroundTeoh, K. W., Ng, C. M., Chong, C. W., Bell, J. S., Cheong, W. L., & Lee, S. W. H. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-003203 · Cited by 68
The risk of tooth loss in patients with diabetes: A systematic review and meta‐analysis
Weijdijk, L. P. M., Žiūkaitė, L., van der Weijden, G. A., Bakker, E. W. P., & Slot, D. E. (2021) · International Journal of Dental Hygiene · doi:10.1111/idh.12512 · Cited by 63
“Total ♂ 6089 ♦ ♀ 9043 ♦ Mean age: ? (18-74)”
Karimifard, M., Aminorroaya, A., Kachuei, A., Salamat, M. R., Alijanvand, M. H., Yamini, S. A., Karimifar, M., Feizi, A., & Amini, M. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12944 · Cited by 57
Myricetin ameliorated prediabetes via immunomodulation and gut microbiota interaction
Yang, L., Gao, Y., Gong, J., Wang, H., Farag, M. A. F., Simal‐Gándara, J., Zhao, Y., Nie, S., & Xiao, J. (2022) · Food Frontiers · doi:10.1002/fft2.152 · Cited by 50
Prediabetes in Adolescents: Prevalence, Management and Diabetes Prevention Strategies
Esquivel-Zuniga, R., & DeBoer, M. D. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s284401 · Cited by 53
“In adult populations, lifestyle interventions decreased the percentage of patients with prediabetes who progressed over a 4-year period to T2DM from 33% to 20%.(40,41) Since generalized screening of children and adolescents with obesity is unlikely to be cost-effective, the ADA and the International Society for Pediat…”
BackgroundWalsh, J. C., & Groarke, J. M. (2019) · European Psychologist · doi:10.1027/1016-9040/a000351 · Cited by 61
“Changing unhealthy lifestyle behaviors, namely poor nutrition and lack of physical activity, are the cornerstone to preventing chronic disease (CDC; Tuso, 2014).”
BackgroundRahim, F. F., Abdulrahman, S. A., Maideen, S. F. K., & Rashid, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228570 · Cited by 57
“Current evidence suggest that diabetes can be prevented at early stage by resolving the progression of prediabetes to diabetes [12, 13].”
BackgroundMosili, P., Mkhize, B. C., Ngubane, P. S., Sibiya, N. H., & Khathi, A. (2020) · Nutrition & Metabolism · doi:10.1186/s12986-020-00532-1 · Cited by 51
Type 2 diabetes epidemic and key risk factors in Qatar: a mathematical modeling analysis
Awad, S. F., Toumi, A. A., Mutawa, K. A. A., Alyafei, S. A., Ijaz, M. A., Khalifa, S. E. A. H., Kokku, S. B., Mishra, A., Poovelil, B. V., Soussi, M. B., et al. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002704 · Cited by 42
The Mechanisms of the Development of Atherosclerosis in Prediabetes
Liang, Y. T., Wang, M., Wang, C., Liu, Y., Naruse, K., & Takahashi, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084108 · Cited by 45
“Currently, lifestyle interventions, such as diet and exercise, are the preferred options [116,117].”
BackgroundSiddiqui, S., Zainal, H., Harun, S. N., Ghadzi, S. M. S., & Ghafoor, S. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.06.069 · Cited by 43
Singh, A., Kaur, N., Kaushal, S., Tyagi, R., Mathur, D., Sivapuram, M. S., Metri, K., Bammidi, S., Podder, V., Modgil, S., et al. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.07.007 · Cited by 42
Metabolic syndrome, glucose tolerance categories and the cardiovascular risk in Spanish population
Martínez-Larrad, M. T., Anchuelo, A. C., Fernández, C., Redondo, Y. L., Escobar‐Jiménez, F., & Serrano‐Ríos, M. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.02.003 · Cited by 42
“[5] Tuso P.”
BackgroundLuo, M., Xu, C., Luo, Y., Wang, G., Wu, J., & Wan, Q. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01430-6 · Cited by 38
Lin, M., Chen, T., & Fan, G. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1111565 · Cited by 44
Zheng, L., Linarelli, L. E., Brooke, J., Smith, C., Wall, S. S., Greenawald, M. H., Seidel, R. W., Estabrooks, P. A., Almeida, F. A., & Cheng, Z. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/5290638 · Cited by 37
Lin, L.-Y., Hsu, C., Lee, H.-A., Wang, W.-H., Kurniawan, A. L., & Chao, J. C.-J. (2019) · Nutrients · doi:10.3390/nu11040845 · Cited by 36
“Lifestyle interventions are highly effective in delaying or preventing the onset of diabetes in people with IGT and may also reduce cardiovascular disease (CVD) and total mortality [23,26].”
BackgroundExpression and clinical significance of miR‑1 and miR‑133 in pre‑diabetes
Al‐Kafaji, G., Al-Muhtaresh, H. A., & Salem, A. H. (2021) · Biomedical Reports · doi:10.3892/br.2021.1409 · Cited by 36
“Intervention strategies such as lifestyle modifications and medications can reduce the risk of progression of pre‐diabetes to T2D (10,11).”
BackgroundTargeted Clinical Metabolite Profiling Platform for the Stratification of Diabetic Patients
Ahonen, L. L., Jäntti, S. E., Suvitaival, T., Theilade, S., Risz, C., Kostiainen, R. K., Rossing, P. R., Orešič, M., & Hyötyläinen, T. (2019) · Metabolites · doi:10.3390/metabo9090184 · Cited by 29
“Prediabetes is a condition with a high risk of progression to T2D, with a yearly conversion rate of 5–10% [1,2].”
Diet and Lifestyle Guidelines for Diabetes: Evidence Based Ayurvedic Perspective
Sharma, R., & Prajapati, P. (2014) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/rjdnmd-2014-0041 · Cited by 40
“It reduced the rate of conversion from Impaired Glucose Tolerance (IGT) or pre-diabetes to type 2 diabetes [65-68].”
BackgroundCE‐MS‐based serum fingerprinting to track evolution of type 2 diabetes mellitus
Ciborowski, M., Adamska-Patruno, E., Rusak, M., Godzień, J., Wilk, J., Citko, A., Bauer, W., Górska, M., & Kretowski, A. J. (2015) · Electrophoresis · doi:10.1002/elps.201500021 · Cited by 28
Chronic Disease and Mobile Technology: An Innovative Tool for Clinicians
Merck, S. F. (2017) · Nursing Forum · doi:10.1111/nuf.12202 · Cited by 26
“Changing unhealthy lifestyle behaviors, namely poor nutrition and lack of physical activity, are the cornerstone to preventing one chronic disease— diabetes (CDC; Tuso, 2014).”
BackgroundDupuit, M., Chavanelle, V., Chassaing, B., Pérrière, F., Etienne, M., Plissonneau, C., Boscaro, A., Barnich, N., Pialoux, V., Maugard, T., et al. (2021) · Nutrients · doi:10.3390/nu13051569 · Cited by 26
“Indeed, 5–10% of patients with prediabetes typically progress to T2D each year [4], and 70% will develop T2D during their lifetime [5].”
BackgroundFujiati, I. I., Damanik, H. A., Bachtiar, A., Nurdin, A. A., & Ward, P. (2017) · Interventional Medicine and Applied Science · doi:10.1556/1646.9.2017.18 · Cited by 30
Hyder, K., Mohan, J., Varma, V., Ponnusankar, S., & Raja, D. (2021) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2021.101395 · Cited by 30
“Interventions on prediabetes can make health care more affordable prevent a preventable disease and control the diabetes epidemic (Tuso, 2014).”
BackgroundSignificance of Lipid Profile Parameters in Predicting Pre-Diabetes.
Jasim, O. H., Mahmood, M. M., & Ad'hiah, A. H. (2022) · PubMed · doi:10.22092/ari.2021.356465.1846 · Cited by 38
Esquivel-Hernandez, D. A., Martínez-López, Y. E., Sánchez-Castañeda, J. P., Neri-Rosario, D., Padrón-Manrique, C., Giron-Villalobos, D., Mendoza-Ortíz, C., & Reséndis-Antonio, O. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1128767 · Cited by 24
“PreT2D can be prevented or delayed through lifestyle modifications, drugs, or bariatric surgery; however, up to 70% of people with preT2D will eventually evolve into T2D (4, 5).”
BackgroundNesto, R., Fain, R., Li, Y., & Shanahan, W. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2016.1178590 · Cited by 20
“[13] Furthermore, several large-scale epidemiologic studies”
Lee, J., Oh, M.-K., Lim, J.-T., Kim, H.-G., & Lee, W. J. (2016) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2016.37.1.7 · Cited by 20
Vaughan, K., Ranawana, V., Cooper, D., & Aceves‐Martins, M. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab069 · Cited by 23
“Kim et al 200839 opted for whole brown seaweed rather than a seaweed extract, supporting in vitro research showing that Laminaria japonica (Kombu) may have potential in managing T2DM.50 Further investigations in diabetic individuals are required in order to clarify the potential of brown seaweeds for regulating plasma…”
BackgroundInfluentialSosibo, A. M., Mzimela, N. C., Ngubane, P. S., & Khathi, A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278347 · Cited by 21
Karandish, M., Mozaffari–Khosravi, H., Mohammadi, S. M., Azhdari, M., & Cheraghian, B. (2020) · Trials · doi:10.1186/s13063-020-04923-w · Cited by 20
Mahoney, S. J., Bradley, A., Pitts, L., Waletzko, S. P., Robinson‐Lane, S. G., Fairchild, T. J., Terbizan, D. J., & McGrath, R. P. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17134706 · Cited by 21
“Early detection and identification of prediabetes and type 2 diabetes are crucial for slowing the progression of the disease and management of comorbidities [13,14,23,24].”
BackgroundAbdulai, T., Li, Y., Zhang, H., Tu, R., Liu, X., Zhang, L., Dong, X., Li, R., Wang, Y., & Wang, C. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-029628 · Cited by 22
Identification of metabolic markers predictive of prediabetes in a Korean population
Lee, H.-S., Park, T. J., Kim, J., Yun, J. H., Yu, H.-Y., Kim, Y. J., & Kim, B. (2020) · Scientific Reports · doi:10.1038/s41598-020-78961-4 · Cited by 16
Batten, R., Alwashmi, M. F., Mugford, G., Nuccio, M., Besner, A., & Gao, Z. (2022) · JMIR Diabetes · doi:10.2196/23243 · Cited by 16
“According to an American Diabetes Association panel [7,8], up to 70% of adults with prediabetes will develop type 2 diabetes.”
BackgroundPerkison, W. B., Rodriguez, S. A., Velasco-Huerta, F., Mathews, P. D., Pulicken, C., Beg, S. S., Heredia, N. I., Fwelo, P., White, G. E., Reininger, B. M., et al. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.933253 · Cited by 17
Kao, T. A., Ling, J., Vu, C., Hawn, R., & christodoulos, H. (2023) · Annals of Behavioral Medicine · doi:10.1093/abm/kaad006 · Cited by 21
“Empirical evidence suggests that combining healthy eating behaviors with the recommended amount of PA may help achieve healthier weights and reduce risk for chronic diseases [6].”
BackgroundWeijdijk, L. P. M., van der Weijden, G. A., & Slot, D. E. (2023) · Journal of Dentistry · doi:10.1016/j.jdent.2023.104628 · Cited by 20
Exploring the recent molecular targets for diabetes and associated complications
Gupta, A. K., Behl, T., Sehgal, A., Bhardwaj, S., Singh, S., Sharma, N., & Hafeez, A. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06294-0 · Cited by 18
Sani, L., Cardinault, N., Astier, J., Darmon, P., & Landrier, J. (2023) · Antioxidants · doi:10.3390/antiox12081481 · Cited by 18
Shi, B., Dhaliwal, S. S., soo, M., chan, C., Wong, J., Lam, N. W. C., Zhou, E., Paitimusa, V., Loke, K. Y., Chin, J., et al. (2023) · JMIR AI · doi:10.2196/48340 · Cited by 29
“Recent evidence also suggests that early lifestyle adjustment will help participants with prediabetes return to normoglycemia and reduce the risk of developing T2DM [19-21].”
BackgroundEffects of Totum-63 on glucose homeostasis and postprandial glycemia: a translational study
Chavanelle, V., Otero, Y. F., Joubioux, F. L., Ripoche, D., Bargetto, M., Vluggens, A., Montaurier, C., Pickering, G., Ducheix, G., Dubray, C., et al. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00629.2020 · Cited by 17
Intervensi Gaya Hidup Terhadap Pencegahan Diabetes Melitus Tipe 2 Pada Pasien Pra Diabetes
Fitriani, F., & Sanghati, S. (2021) · JURNAL ILMIAH KESEHATAN SANDI HUSADA · doi:10.35816/jiskh.v10i2.682 · Cited by 41
Hashemi, S. J., Karandish, M., Cheraghian, B., & Azhdari, M. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-00990-z · Cited by 19
“The subjects with older age, living in a rural area, unhealthy diet, overweight, obesity, abnormal waist circumference (WC), high waist-to-hip ratio (WHR), low physical activity (PA), smoking habits, marital status, education levels, excessive alcohol, history of diseases (metabolic syndrome and HTN and hypertriglycer…”
BackgroundInfluentialAlterations in ventral attention network connectivity in individuals with prediabetes
Sadler, J. R., Shearrer, G. E., & Burger, K. S. (2019) · Nutritional Neuroscience · doi:10.1080/1028415x.2019.1609646 · Cited by 13
Oral Azelaic Acid Ester Decreases Markers of Insulin Resistance in Overweight Human Male Subjects
Streeper, R. T., Louden, C., & Izbicka, E. (2020) · In Vivo · doi:10.21873/invivo.11890 · Cited by 17
Richardson, K. M., Schembre, S. M., da Silva, V., Blew, R. M., Behrens, N., Roe, D. J., Marvasti, F. F., & Hingle, M. D. (2024) · Journal of Diabetes Research · doi:10.1155/2024/7687694 · Cited by 15
“More than one-third of US adults have prediabetes [1], and up to 70% of individuals with prediabetes progress to type 2 diabetes (T2DM) [2], a serious metabolic disease conferring increased risk of cardiovascular disease and stroke [3], and contributing to greater lifetime disability, economic…”
BackgroundBasiri, R., & Rajanala, Y. (2025) · Nutrients · doi:10.3390/nu17091507 · Cited by 15
Lukács, A., Kiss-Tóth, E., Csordás, Á., Sasvári, P., & Barkai, L. (2017) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2017.01.006 · Cited by 13
Hall, C. V., Twelves, J. L., Saxena, M., Scapozza, L., & Gurry, T. (2024) · British Journal Of Nutrition · doi:10.1017/s0007114524000904 · Cited by 11
“However, evidence suggests that initiating treatment in pre-diabetes, where patients are earlier and less advanced in the diabetic disease pathway, may result in faster clinical improvements that are maintained long term (3 – 6) .”
Bình, T. Q., Thu, N. T. T., Phương, P. T., Nhung, B. T., & Nhung, T. T. H. (2015) · BMC Genetics · doi:10.1186/s12863-015-0266-0 · Cited by 12
“However, prediabetes is reversible and its related metabolic disorders can be improved with proper treatment [6].”
BackgroundPathophysiological Ramifications of Diabetic Condition: A Review
Shahi, A., Vss, P., Imam, S. S., Muheem, A., & Jahangir, M. A. (2018) · Asian journal of biomedical and pharmaceutical sciences · doi:10.4066/2249-622x.65.18-845 · Cited by 15
“According to the report of WHO, the number of people with diabetes rose from 108 million in 1980 to 422 million in 2014 [3].”
BackgroundAramo, C., Oyom, A. P., Okello, E., Acam, V., Okiria, J. C., Mwambi, B., & Oyet, C. (2019) · BMC Research Notes · doi:10.1186/s13104-019-4589-1 · Cited by 12
Hosseini, M., Nezhadali, M., & Hedayati, M. (2020) · Journal of Medical Biochemistry · doi:10.5937/jomb0-24671 · Cited by 12
“Pre-diabetics have an increased risk of T2DM than healthy people and are more capable of becoming diabetic population in the future (4).”
BackgroundImaging of Sarcopenia in Type 2 Diabetes Mellitus
Wang, D., Zhang, G., Yu, Y., & Zhang, Z. (2024) · Clinical Interventions in Aging · doi:10.2147/cia.s443572 · Cited by 11
Hjorth, P., Espensen, C. H., Madsen, N. J., Viuff, A. G., & Munk‐Jørgensen, P. (2018) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000278 · Cited by 11
Kao, T. A., Ling, J., Hawn, R., & Vu, C. (2021) · Obesity Reviews · doi:10.1111/obr.13308 · Cited by 13
Ramaswamy, G., Chinnakali, P., Selvaraju, S., Nair, D., Thekkur, P., Selvaraj, K., Shivashankar, R., Singh, A. R., & Nanjundappa, V. H. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.12.001 · Cited by 11
Statins are associated with new onset type 2 diabetes mellitus (T2DM) in Medicare patients ≥65 years
Tangelloju, S., Little, B. B., Esterhay, R. J., Brock, G. N., & Lajoie, S. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3310 · Cited by 13
“sugar is higher than normal, but not high enough to be classified as T2DM.(7) Without intervention, pre-diabetes will progress to T2DM onset.”
BackgroundAlamdary, S. Z., Afifirad, R., Asgharzadeh, S., Asadollahi, P., Ari, M. M., Dashtibin, S., Sabaghan, M., Shokouhamiri, M. R., Ghanavati, R., & Darbandi, A. (2022) · International Journal of Clinical Practice · doi:10.1155/2022/5963679 · Cited by 13
“A study was qualified for inclusion if the following criteria were met: in [1] the study was a RCT; in [2] it was conducted on prestate diabetic patients who had been given probiotics; [3] was published in English language from 2010 to 2020.”
Serum Branched Chain Amino Acids Are Associated with Type 2 Diabetes Mellitus in Jordan
Alfaqih, M. A., Abu-Khdair, Z. E., Saadeh, R., Saadeh, N. A., Al‐Dwairi, A., & Al-Shboul, O. A. (2018) · Korean Journal of Family Medicine · doi:10.4082/kjfm.17.0122 · Cited by 14
Hossain, M. B., Khan, M. N., Oldroyd, J. C., Rana, J., Magliano, D. J., Chowdhury, E., Karim, M. N., & Islam, R. M. (2021) · medRxiv · doi:10.1101/2021.01.26.21250519 · Cited by 11
“implication is that diabetes prevention programmes need to continue targeting those with prediabetes to help delay this preventable disease early in its pathogenesis, reducing disease burden[29].”
Family Involvement to Stop the Conversion of Prediabetes to Diabetes
Prakoso, D. A., Mahendradhata, Y., & Istiono, W. (2023) · Korean Journal of Family Medicine · doi:10.4082/kjfm.23.0019 · Cited by 11
Zhen, J., Zhang, Y., Li, Y., Zhou, Y., Cai, Y., Huang, G., & Xu, A. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1423662 · Cited by 10
“However, the progression from a healthy state to diabetes may take several years or even more than a decade, and this individualized progression can be observed in clinical settings (Tabak et al., 2012; Tuso, 2014; Knight et al., 2017).”
Zhu, H., Fu, Q., Chen, R., Luo, L., Yu, M., & Zhou, Y. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1483045 · Cited by 12
“Extensive longitudinal research has substantiated that adopting lifestyle modifications can notably extend the timeline before the transition from a prediabetic state to diabetes, with benefits observed over a decade (31).”
Zhu, W., Shi, P., Fu, J., Liang, A., Zheng, T., Wu, X., & Yuan, S. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01752-5 · Cited by 12
“Such screening and intervention during prediabetes could also potentially aid in reducing NAFLD risk [30, 31]; however, the prediabetic population, particularly those who are lean, are often ignored in clinical practice until they had already progressed to T2DM or NAFLD.”
BackgroundBarua, M., Pathan, F., Nabi, M. U., & Kabir, M. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.03.019 · Cited by 10
How patients make sense of a diabetes diagnosis: An application of Weick’s model of organizing
Ledford, C. J. W., Fisher, C. L., Cafferty, L. A., Jackson, J. T., Crawford, P. F., & Seehusen, D. A. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108117 · Cited by 10
Xue, Y., Liu, C., Wang, B., Mao, Z., Yu, S., Wang, Y., Zhang, D., Wang, C., Li, W., & Li, X. (2021) · Public Health Nutrition · doi:10.1017/s1368980021000227 · Cited by 13
A Community-Based Prediabetes Knowledge Assessment among Saudi Adults in Al-Ahsa Region, 2018
AlSaleh, E. M., Alnaser, M., Alsalman, A., Al-Ramdhan, A., Alsalman, H., Alhamrani, O. H., Alhamrani, A. H. A., AlSaleh, M. E., AlEithan, T., AlArfaj, K., et al. (2021) · Journal of Public Health Research · doi:10.4081/jphr.2021.2032 · Cited by 12
Prevalence of Metabolic Syndrome in Prediabetes
Rajput, R., Rajput, M., Mishra, S., & Ahlawat, P. (2019) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2019.0010 · Cited by 12
“The average age of cases in our study was much lower compared with estimates of Western counterparts 19 metabolic syndrome in our study was seen to increase in subjects with increasing age, which shows a positive dose– response relationship between age and the prevalence of metabolic syndrome.”
Velasco, L. M. P., Esparza, W. D., Aladro-Gonzalvo, A. R., & Segovia, E. L. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18041378 · Cited by 17
“Whilst prediabetes is not considered a clinical illness, it can lead to a higher incidence of diabetes and cardiovascular disease [3,4].”
BackgroundTargeted Clinical Metabolomics Platform for the Stratification of Diabetic PatientsPreprint
Ahonen, L. L., Jäntti, S. E., Suvitaival, T., Theilade, S., Risz, C., Kostiainen, R. K., Rossing, P. R., Orešič, M., & Hyötyläinen, T. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/664052 · Cited by 10
Kim, H. J., Lim, Y., Yoon, S. S., Lee, S. J., Lee, M. H., Park, H., Park, S. J., Jeong, S., & Han, H. W. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-2195 · Cited by 8
“Several studies have shown that early detection and treatment of diabetes can delay the progression of the disease and prevent complications (18-20).”
Physical inactivity and barriers to physical activity among Type-2 diabetics in Kumasi, Ghana
Taylor, L. K., Nyakotey, D. A., & Kwarteng, A. (2023) · African Health Sciences · doi:10.4314/ahs.v23i3.38 · Cited by 13
Brateanu, A., Barwacz, T., Kou, L., Wang, S., Misra‐Hebert, A. D., Hu, B., Deshpande, A., Kobaivanova, N., & Rothberg, M. B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187695 · Cited by 9
Modelling the spread of diabetes transmission through social contact
Kompas, S., Aldila, D., & Handari, B. D. (2020) · AIP conference proceedings · doi:10.1063/5.0030458 · Cited by 9
Metadata
- Authors
- Tuso, P.
- Affiliations
- Care Management Institute Physician Lead for Total Health..
- Corresponding author
- Tuso, Phillip
- Venue
- The Permanente Journal
- Publisher
- The Permanente Federation
- Published
- 2014-09
- Volume
- 18
- Issue
- 3
- Pages
- 88-93
- ISSN
- 1552-5767 (ISSN-L)
- 1552-5775
- PMC
- PMC4116271
- OpenAlex
- W2031370419
- Cited by
- 252
- References
- 46
- Citations by year
- 2026: 11 · 2025: 27 · 2024: 23 · 2023: 24 · 2022: 30 · 2021: 35 · 2020: 37 · 2019: 24 · 2018: 16 · 2017: 9 · 2016: 9 · 2015: 5 · 2014: 2
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Permanente Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- prediabetes, type 2 diabetes prevention, lifestyle modification, lifestyle intervention, overweight, physical inactivity, risk stratification, Diabetes Prevention Program, cost-effectiveness, return on investment, blood glucose
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Blood Glucose, Cost-Benefit Analysis, Diabetes Mellitus, Type 2, Female, Humans, Life Style, Male, Middle Aged, Obesity, Patient Education as Topic, Prediabetic State, Risk Factors, United States, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.